ID KCNU1_HUMAN Reviewed; 1149 AA. AC A8MYU2; B4DYE4; DT 02-SEP-2008, integrated into UniProtKB/Swiss-Prot. DT 02-SEP-2008, sequence version 2. DT 02-SEP-2026, entry version 145. DE RecName: Full=Potassium channel subfamily U member 1; DE AltName: Full=Calcium-activated potassium channel subunit alpha-3; DE AltName: Full=Calcium-activated potassium channel, subfamily M subunit alpha-3; DE AltName: Full=KCa5; DE AltName: Full=Slowpoke homolog 3; GN Name=KCNU1 {ECO:0000312|HGNC:HGNC:18867}; GN Synonyms=KCNMA3, KCNMC1, SLO3 {ECO:0000303|PubMed:9452476}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-916. RC TISSUE=Testis; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16421571; DOI=10.1038/nature04406; RA Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M., RA Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L., RA Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S., RA Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A., RA Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III, RA Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., RA Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P., RA Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H., RA Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B., RA O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K., RA Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L., RA Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G., RA Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W., RA Platzer M., Shimizu N., Lander E.S.; RT "DNA sequence and analysis of human chromosome 8."; RL Nature 439:331-335(2006). RN [3] RP FUNCTION, AND TISSUE SPECIFICITY. RX PubMed=9452476; DOI=10.1074/jbc.273.6.3509; RA Schreiber M., Wei A., Yuan A., Gaut J., Saito M., Salkoff L.; RT "Slo3, a novel pH-sensitive K+ channel from mammalian spermatocytes."; RL J. Biol. Chem. 273:3509-3516(1998). RN [4] RP X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 330-1063, FUNCTION, TRANSPORTER RP ACTIVITY, SUBUNIT, AND ACTIVITY REGULATION. RX PubMed=23129643; DOI=10.1073/pnas.1215078109; RA Leonetti M.D., Yuan P., Hsiung Y., Mackinnon R.; RT "Functional and structural analysis of the human SLO3 pH- and voltage-gated RT K+ channel."; RL Proc. Natl. Acad. Sci. U.S.A. 109:19274-19279(2012). RN [5] RP FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY REGULATION, AND SUBCELLULAR RP LOCATION. RX PubMed=24670955; DOI=10.7554/elife.01438; RA Brenker C., Zhou Y., Mueller A., Echeverry F.A., Troetschel C., Poetsch A., RA Xia X.M., Boenigk W., Lingle C.J., Kaupp U.B., Struenker T.; RT "The Ca2+-activated K+ current of human sperm is mediated by Slo3."; RL Elife 3:e01438-e01438(2014). RN [6] RP FUNCTION, AND ACTIVITY REGULATION. RX PubMed=36649421; DOI=10.1073/pnas.2212338120; RA Lyon M., Li P., Ferreira J.J., Lazarenko R.M., Kharade S.V., Kramer M., RA McClenahan S.J., Days E., Bauer J.A., Spitznagel B.D., Weaver C.D., RA Borrego Alvarez A., Puga Molina L.C., Lybaert P., Khambekar S., Liu A., RA Lindsley C.W., Denton J., Santi C.M.; RT "A selective inhibitor of the sperm-specific potassium channel SLO3 impairs RT human sperm function."; RL Proc. Natl. Acad. Sci. U.S.A. 120:e2212338120-e2212338120(2023). RN [7] RP FUNCTION, ACTIVITY REGULATION, AND SUBCELLULAR LOCATION. RX PubMed=38267364; DOI=10.1093/biolre/ioae004; RA Zhang J., Zheng L., Chen Y., Luo T., Zeng X., Kang H.; RT "LRRC52 is likely a functional component of human KSper."; RL Biol. Reprod. 0:0-0(2024). RN [8] RP INVOLVEMENT IN SPGF79, VARIANT SPGF79 ARG-715, CHARACTERIZATION OF VARIANT RP SPGF79 ARG-715, FUNCTION, AND TISSUE SPECIFICITY. RX PubMed=35551387; DOI=10.1093/humrep/deac102; RA Liu R., Yan Z., Fan Y., Qu R., Chen B., Li B., Wu L., Wu H., Mu J., RA Zhao L., Wang W., Dong J., Zeng Y., Li Q., Wang L., Sang Q., Zhang Z., RA Kuang Y.; RT "Bi-allelic variants in KCNU1 cause impaired acrosome reactions and male RT infertility."; RL Hum. Reprod. 37:1394-1405(2022). RN [9] RP VARIANT SPGF79 PHE-413, CHARACTERIZATION OF VARIANT SPGF79 PHE-413, RP FUNCTION, AND TISSUE SPECIFICITY. RX PubMed=34980136; DOI=10.1186/s12958-021-00880-4; RA Lv M., Liu C., Ma C., Yu H., Shao Z., Gao Y., Liu Y., Wu H., Tang D., RA Tan Q., Zhang J., Li K., Xu C., Geng H., Zhang J., Li H., Mao X., Ge L., RA Fu F., Zhong K., Xu Y., Tao F., Zhou P., Wei Z., He X., Zhang F., Cao Y.; RT "Homozygous mutation in SLO3 leads to severe asthenoteratozoospermia due to RT acrosome hypoplasia and mitochondrial sheath malformations."; RL Reprod. Biol. Endocrinol. 20:5-5(2022). CC -!- FUNCTION: Testis-specific potassium channel activated by both CC intracellular pH and membrane voltage that mediates export of K(+) CC (PubMed:23129643, PubMed:24670955, PubMed:36649421, PubMed:38267364, CC PubMed:9452476). Represents the primary spermatozoan K(+) current. The CC channel underlies a pH-triggered membrane hyperpolarization during the CC process of sperm capacitation, as sperm encounter the alkaline CC environment near the ovum in the female reproductive tract, thereby CC playing an essential for male fertility (PubMed:34980136, CC PubMed:35551387, PubMed:36649421). {ECO:0000269|PubMed:23129643, CC ECO:0000269|PubMed:24670955, ECO:0000269|PubMed:34980136, CC ECO:0000269|PubMed:35551387, ECO:0000269|PubMed:36649421, CC ECO:0000269|PubMed:38267364, ECO:0000269|PubMed:9452476}. CC -!- CATALYTIC ACTIVITY: CC Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103; CC Evidence={ECO:0000269|PubMed:23129643, ECO:0000269|PubMed:24670955}; CC -!- ACTIVITY REGULATION: Regulated by changes in cytosolic pH; activated by CC alkalization (PubMed:23129643, PubMed:24670955). Activated by CC intracellular Ca(2+) (PubMed:24670955). Despite strong sequence CC similarity, human KCNU1 channels are significantly more sensitive to CC activation by internal Ca(2+) and less pH-sensitive than mouse KCNU1 CC (PubMed:24670955). VU0546110 acts as a selective inhibitor CC (PubMed:36649421). The auxiliary subunit LRRC52 shifts the activation CC of KCNU1 to more negative potentials at a given pH (PubMed:38267364). CC {ECO:0000269|PubMed:23129643, ECO:0000269|PubMed:24670955, CC ECO:0000269|PubMed:36649421, ECO:0000269|PubMed:38267364}. CC -!- SUBUNIT: Homotetramer; which constitutes the activated potassium CC channel (By similarity). Interacts with LRRC52; this interaction CC changes channel gating properties, such as shifting gating to more CC negative potentials at a given pH (PubMed:38267364). CC {ECO:0000250|UniProtKB:Q12791, ECO:0000269|PubMed:38267364}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O54982}; CC Multi-pass membrane protein {ECO:0000255}. Cell projection, cilium, CC flagellum membrane {ECO:0000269|PubMed:24670955, CC ECO:0000269|PubMed:38267364}; Multi-pass membrane protein CC {ECO:0000255}. CC -!- TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:34980136, CC ECO:0000269|PubMed:35551387, ECO:0000269|PubMed:9452476}. CC -!- DOMAIN: The S4 segment, which is characterized by a series of CC positively charged amino acids at every third position, is part of the CC voltage-sensor. {ECO:0000250}. CC -!- DOMAIN: The pore-forming domain (also referred as P region) is imbedded CC into the membrane, and forms the selectivity filter of the pore. It CC contains the signature sequence of potassium channels that displays CC selectivity to potassium (By similarity). {ECO:0000250}. CC -!- DOMAIN: The RCK N-terminal domain mediates the homotetramerization, CC thereby promoting the assembly of monomers into functional potassium CC channel. {ECO:0000250|UniProtKB:Q12791}. CC -!- DOMAIN: The C-terminal cytosolic region confers the pH-dependence. CC {ECO:0000250}. CC -!- DISEASE: Spermatogenic failure 79 (SPGF79) [MIM:620196]: An autosomal CC recessive, male infertility disorder characterized by CC asthenoteratozoospermia with acrosome hypoplasia, disruption of the CC mitochondrial sheath, and reduced progressive sperm motility. The CC disorder is due to an abnormal acrosome reaction and impaired membrane CC potential after capacitation. {ECO:0000269|PubMed:34980136, CC ECO:0000269|PubMed:35551387}. Note=The disease is caused by variants CC affecting the gene represented in this entry. CC -!- SIMILARITY: Belongs to the potassium channel family. Calcium-activated CC (TC 1.A.1.3) subfamily. KCa5.1/KCNU1 sub-subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AC124076; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AK302391; BAG63706.1; -; mRNA. DR CCDS; CCDS55220.1; -. DR RefSeq; NP_001027006.2; NM_001031836.3. DR PDB; 4HPF; X-ray; 3.40 A; A/B=330-1062. DR AlphaFoldDB; A8MYU2; -. DR SMR; A8MYU2; -. DR DIP; DIP-60091N; -. DR FunCoup; A8MYU2; 252. DR STRING; 9606.ENSP00000382770; -. DR ChEMBL; CHEMBL4524132; -. DR GuidetoPHARMACOLOGY; 387; -. DR GlyCosmos; A8MYU2; 1 site, 1 glycan. DR GlyGen; A8MYU2; 2 sites, 4 N-linked glycans (2 sites). DR iPTMnet; A8MYU2; -. DR PhosphoSitePlus; A8MYU2; -. DR BioMuta; KCNU1; -. DR MassIVE; A8MYU2; -. DR PaxDb; 9606-ENSP00000382770; -. DR PeptideAtlas; A8MYU2; -. DR ProteomicsDB; 2426; -. DR Antibodypedia; 57826; 75 antibodies from 13 providers. DR DNASU; 157855; -. DR Ensembl; ENST00000399881.8; ENSP00000382770.3; ENSG00000215262.8. DR GeneID; 157855; -. DR KEGG; hsa:157855; -. DR MANE-Select; ENST00000399881.8; ENSP00000382770.3; NM_001031836.3; NP_001027006.2. DR UCSC; uc010lvw.5; human. DR AGR; HGNC:18867; -. DR ClinPGx; PA38727; -. DR CTD; 157855; -. DR DisGeNET; 157855; -. DR GeneCards; KCNU1; -. DR HGNC; HGNC:18867; KCNU1. DR HPA; ENSG00000215262; Tissue enriched (testis). DR MalaCards; KCNU1; -. DR MIM; 615215; gene. DR MIM; 620196; phenotype. DR OpenTargets; ENSG00000215262; -. DR VEuPathDB; HostDB:ENSG00000215262; -. DR eggNOG; KOG1420; Eukaryota. DR GeneTree; ENSGT00940000161817; -. DR InParanoid; A8MYU2; -. DR OMA; NWNTGDN; -. DR OrthoDB; 10035564at2759; -. DR PAN-GO; A8MYU2; 3 GO annotations based on evolutionary models. DR PhylomeDB; A8MYU2; -. DR PathwayCommons; A8MYU2; -. DR Reactome; R-HSA-1300642; Sperm Motility And Taxes. DR SignaLink; A8MYU2; -. DR Agora; ENSG00000215262; -. DR BioGRID-ORCS; 157855; 9 hits in 1147 CRISPR screens. DR ChiTaRS; KCNU1; human. DR EvolutionaryTrace; A8MYU2; -. DR GeneWiki; KCNU1; -. DR GenomeRNAi; 157855; -. DR Pharos; A8MYU2; Tbio. DR PRO; PR:A8MYU2; -. DR Proteomes; UP000005640; Chromosome 8. DR RNAct; A8MYU2; protein. DR Bgee; ENSG00000215262; Expressed in sperm and 52 other cell types or tissues. DR ExpressionAtlas; A8MYU2; baseline and differential. DR GO; GO:0016020; C:membrane; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; ISS:UniProtKB. DR GO; GO:0036126; C:sperm flagellum; IDA:UniProtKB. DR GO; GO:0005267; F:potassium channel activity; IMP:UniProtKB. DR GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB. DR GO; GO:0022414; P:reproductive process; IMP:UniProtKB. DR FunFam; 3.40.50.720:FF:000005; calcium-activated potassium channel subunit alpha-1 isoform X6; 1. DR FunFam; 1.10.287.70:FF:000130; Potassium calcium-activated channel subfamily U member 1; 1. DR FunFam; 3.40.50.720:FF:000403; Potassium calcium-activated channel subfamily U member 1; 1. DR Gene3D; 1.10.287.70; -; 1. DR Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 2. DR InterPro; IPR005821; Ion_trans_dom. DR InterPro; IPR003929; K_chnl_BK_asu. DR InterPro; IPR047871; K_chnl_Slo-like. DR InterPro; IPR003148; RCK_N. DR InterPro; IPR048735; Slowpoke-like_C. DR PANTHER; PTHR10027; CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA CHAIN; 1. DR PANTHER; PTHR10027:SF23; POTASSIUM CHANNEL SUBFAMILY U MEMBER 1; 1. DR Pfam; PF03493; BK_channel_a; 1. DR Pfam; PF00520; Ion_trans; 1. DR Pfam; PF22614; Slo-like_RCK; 2. DR Pfam; PF21014; Slowpoke_C; 1. DR PRINTS; PR01449; BKCHANNELA. DR SUPFAM; SSF81324; Voltage-gated potassium channels; 1. DR PROSITE; PS51201; RCK_N; 2. DR PDBsum; 4HPF; -. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Cell projection; Cilium; Disease variant; KW Flagellum; Ion channel; Ion transport; Membrane; Potassium; KW Potassium channel; Potassium transport; Proteomics identification; KW Reference proteome; Transmembrane; Transmembrane helix; Transport; KW Voltage-gated channel. FT CHAIN 1..1149 FT /note="Potassium channel subfamily U member 1" FT /id="PRO_0000349186" FT TOPO_DOM 1..24 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 25..45 FT /note="Helical; Name=Segment S0" FT /evidence="ECO:0000255" FT TOPO_DOM 46..101 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 102..122 FT /note="Helical; Name=Segment S1" FT /evidence="ECO:0000255" FT TOPO_DOM 123..138 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 139..159 FT /note="Helical; Name=Segment S2" FT /evidence="ECO:0000255" FT TOPO_DOM 160..163 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 164..184 FT /note="Helical; Name=Segment S3" FT /evidence="ECO:0000255" FT TOPO_DOM 185..188 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 189..209 FT /note="Helical; Voltage-sensor; Name=Segment S4" FT /evidence="ECO:0000255" FT TOPO_DOM 210..226 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 227..247 FT /note="Helical; Name=Segment S5" FT /evidence="ECO:0000255" FT TOPO_DOM 248..259 FT /note="Extracellular" FT /evidence="ECO:0000255" FT INTRAMEM 260..282 FT /note="Pore-forming; Name=P region" FT /evidence="ECO:0000255" FT TOPO_DOM 283..291 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 292..312 FT /note="Helical; Name=Segment S6" FT /evidence="ECO:0000255" FT TOPO_DOM 313..1149 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 331..473 FT /note="RCK N-terminal 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00543" FT DOMAIN 713..884 FT /note="RCK N-terminal 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00543" FT REGION 828..854 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1118..1149 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 276..279 FT /note="Selectivity for potassium" FT COMPBIAS 830..840 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1125..1135 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT VARIANT 175 FT /note="D -> N (in dbSNP:rs1111125)" FT /id="VAR_060148" FT VARIANT 413 FT /note="I -> F (in SPGF79; severely decreased protein FT abundance in patient sperm; dbSNP:rs377269265)" FT /evidence="ECO:0000269|PubMed:34980136" FT /id="VAR_088020" FT VARIANT 715 FT /note="H -> R (in SPGF79; no protein detected in patient FT sperm; a knockin mouse model recapitulates the phenotype of FT male infertility)" FT /evidence="ECO:0000269|PubMed:35551387" FT /id="VAR_088021" FT VARIANT 768 FT /note="W -> R (in dbSNP:rs28608091)" FT /id="VAR_053868" FT VARIANT 916 FT /note="N -> S (in dbSNP:rs16885577)" FT /evidence="ECO:0000269|PubMed:14702039" FT /id="VAR_053869" FT CONFLICT 713 FT /note="R -> Q (in Ref. 1; BAG63706)" FT /evidence="ECO:0000305" FT STRAND 333..338 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 342..349 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 363..365 FT /evidence="ECO:0007829|PDB:4HPF" FT TURN 382..385 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 386..388 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 397..403 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 405..407 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 408..413 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 422..439 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 445..448 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 452..456 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 457..460 FT /evidence="ECO:0007829|PDB:4HPF" FT TURN 466..469 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 471..473 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 475..488 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 492..498 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 512..521 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 527..529 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 532..534 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 539..549 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 553..558 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 571..573 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 585..591 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 593..597 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 598..600 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 685..690 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 697..700 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 716..720 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 732..735 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 736..739 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 745..747 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 748..750 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 751..755 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 757..763 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 764..767 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 771..778 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 783..788 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 791..793 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 795..800 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 801..804 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 815..825 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 861..864 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 868..870 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 871..878 FT /evidence="ECO:0007829|PDB:4HPF" FT TURN 882..884 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 889..891 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 893..897 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 899..901 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 903..907 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 909..915 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 917..928 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 962..966 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 968..971 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 972..975 FT /evidence="ECO:0007829|PDB:4HPF" FT HELIX 982..993 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 996..1003 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 1015..1020 FT /evidence="ECO:0007829|PDB:4HPF" FT STRAND 1032..1037 FT /evidence="ECO:0007829|PDB:4HPF" SQ SEQUENCE 1149 AA; 129543 MW; BA527F41498B6AA7 CRC64; MFQTKLRNET WEDLPKMSCT TEIQAAFILS SFVTFFSGLI ILLIFRLIWR SVKKWQIIKG TGIILELFTS GTIARSHVRS LHFQGQFRDH IEMLLSAQTF VGQVLVILVF VLSIGSLIIY FINSADPVGS CSSYEDKTIP IDLVFNAFFS FYFGLRFMAA DDKIKFWLEM NSIVDIFTIP PTFISYYLKS NWLGLRFLRA LRLLELPQIL QILRAIKTSN SVKFSKLLSI ILSTWFTAAG FIHLVENSGD PWLKGRNSQN ISYFESIYLV MATTSTVGFG DVVAKTSLGR TFIMFFTLGS LILFANYIPE MVELFANKRK YTSSYEALKG KKFIVVCGNI TVDSVTAFLR NFLRDKSGEI NTEIVFLGET PPSLELETIF KCYLAYTTFI SGSAMKWEDL RRVAVESAEA CLIIANPLCS DSHAEDISNI MRVLSIKNYD STTRIIIQIL QSHNKVYLPK IPSWNWDTGD NIICFAELKL GFIAQGCLVP GLCTFLTSLF VEQNKKVMPK QTWKKHFLNS MKNKILTQRL SDDFAGMSFP EVARLCFLKM HLLLIAIEYK SLFTDGFCGL ILNPPPQVRI RKNTLGFFIA ETPKDVRRAL FYCSVCHDDV FIPELITNCG CKSRSRQHIT VPSVKRMKKC LKGISSRISG QDSPPRVSAS TSSISNFTTR TLQHDVEQDS DQLDSSGMFH WCKPTSLDKV TLKRTGKSKY KFRNHIVACV FGDAHSAPMG LRNFVMPLRA SNYTRKELKD IVFIGSLDYL QREWRFLWNF PQIYILPGCA LYSGDLHAAN IEQCSMCAVL SPPPQPSSNQ TLVDTEAIMA TLTIGSLQID SSSDPSPSVS EETPGYTNGH NEKSNCRKVP ILTELKNPSN IHFIEQLGGL EGSLQETNLH LSTAFSTGTV FSGSFLDSLL ATAFYNYHVL ELLQMLVTGG VSSQLEQHLD KDKVYGVADS CTSLLSGRNR CKLGLLSLHE TILSDVNPRN TFGQLFCGSL DLFGILCVGL YRIIDEEELN PENKRFVITR PANEFKLLPS DLVFCAIPFS TACYKRNEEF SLQKSYEIVN KASQTTETHS DTNCPPTIDS VTETLYSPVY SYQPRTNSLS FPKQIAWNQS RTNSIISSQI PLGDNAKENE RKTSDEVYDE DPFAYSEPL //